(1)
Lassen, U.; Henrik Jensen, L.; Sorensen, M.; Rohrberg, K. S.; Ujmajuridze, Z.; Jakobsen, A. A Phase I–II Dose Escalation Study of Fixed-Dose Rate Gemcitabine, Oxaliplatin and Capecitabine Every Two Weeks in Advanced Cholangiocarcinomas. AO 2011, 50, 448-454.